Literature DB >> 31485870

The impact of peak estradiol during controlled ovarian stimulation on the cumulative live birth rate of IVF/ICSI in non-PCOS patients.

Wanlin Zhang1, Ying Tian2, Duo Xie3, Ye Miao1, Jin Liu1, Xiaohong Wang4.   

Abstract

OBJECTIVE: The study aimed to investigate the impact of the peak E2 level during controlled ovarian hyperstimulation (COS) on the cumulative live birth rate (cLBR) in non-PCOS women with normal ovarian reserve.
MATERIALS AND METHODS: Women between 20 and 39 years were included. Donor cycles and patients who never experienced embryo transfer were excluded. Multivariable regression and smooth curve fitting were applied for statistical analysis.
RESULTS: A total of 1141 patients were included. The mean age, basal AFC, peak E2 level, and number of retrieved oocyte were 30.0 ± 3.7 years old, 16.8 ± 6.7, 3911.0 ± 1302.9 pg/ml, and 13.6 ± 5.5, respectively. In the overall population of the cohort, cLBR, miscarriage rate, and preterm birth rate were 66.9%, 7.4%, and 13.7%, respectively. The results of multivariable regression analysis failed to show the impact of peak E2 on the cLBR [OR (95%CI) 0.995 (0.982, 1.009), P = 0.486]. However, the result of smooth curve fitting indicated that when the peak E2 was lower than 2185 pg/ml, the cLBR increased about 12% with 100 pg/ml increasing of the peak E2. When the peak E2 was higher than 6136 pg/ml, the cLBR decreased about 10% with 100 pg/ml increasing of the peak E2.
CONCLUSION: We concluded that the peak E2 level on hCG trigger day is associated with the cLBR in a segmental pattern. There should be an appropriate range of the peak E2 level during COS to achieve a relative best cLBR in non-PCOS patients using stimulating protocol mainly based on GnRH agonist; however, the cutoff value must vary in different centers.

Entities:  

Keywords:  Cumulative live birth rate; In vitro fertilization; Peak estradiol; Retrospective cohort study

Mesh:

Substances:

Year:  2019        PMID: 31485870      PMCID: PMC6885456          DOI: 10.1007/s10815-019-01568-w

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  6 in total

1.  The Association Between Serum Estradiol Levels on hCG Trigger Day and Live Birth Rates in Non-PCOS Patients: A Retrospective Cohort Study.

Authors:  Xiaoyuan Xu; Aimin Yang; Yan Han; Wei Wang; Guimin Hao; Na Cui
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-03       Impact factor: 6.055

2.  Clinical significance of combined detection of anti-Mullerian hormone and follicular output rate in women of late reproductive age.

Authors:  Hui Su; Lili Zuo; Yangyang Wu; Lisong Niu; Yan Wu; Hairu Sun
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

3.  Cumulative Live Birth Rates After the First ART Cycle Using Flexible GnRH Antagonist Protocol vs. Standard Long GnRH Agonist Protocol: A Retrospective Cohort Study in Women of Different Ages and Various Ovarian Reserve.

Authors:  Wanlin Zhang; Duo Xie; Hengde Zhang; Jianlei Huang; Xifeng Xiao; Binrong Wang; Yafei Tong; Ye Miao; Xiaohong Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-08       Impact factor: 5.555

4.  Effect of Hyperinsulinemia and Insulin Resistance on Endocrine, Metabolic, and Reproductive Outcomes in Non-PCOS Women Undergoing Assisted Reproduction: A Retrospective Cohort Study.

Authors:  Wang-Yu Cai; Xi Luo; Jianyuan Song; Danpin Ji; Jun Zhu; Cuicui Duan; Wei Wu; Xiao-Ke Wu; Jian Xu
Journal:  Front Med (Lausanne)       Date:  2022-01-07

5.  Prediction of miscarriage in first trimester by serum estradiol, progesterone and β-human chorionic gonadotropin within 9 weeks of gestation.

Authors:  Wenhui Deng; Rui Sun; Jun Du; Xue Wu; Lijie Ma; Min Wang; Qiubo Lv
Journal:  BMC Pregnancy Childbirth       Date:  2022-02-10       Impact factor: 3.007

6.  High levels estradiol affect blastocyst implantation and post-implantation development directly in mice.

Authors:  Ko-Tung Chang; Yu-Ting Su; Yi-Ru Tsai; Kuo-Chung Lan; Yan-Der Hsuuw; Hong-Yo Kang; Wen-Hsiung Chan; Fu-Jen Huang
Journal:  Biomed J       Date:  2021-01-16       Impact factor: 7.892

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.